26.5 C
New York
Monday, August 8, 2022

Buy now

Protest for psilocybin access planned for DEA’s HQ

psilocybin, fungus, psychedelic, entheogen
Window to the soul: Dawn. Painting by Anthony S. Conrad

Proponents of her case have been working to make the actual transcript of this statement available online. Reformers say the DEA has arbitrarily enforced an illegal ban on entheogenic fungi for the past two years.

Passed through Congress and signed by former President Trump in 2018, the The right to prove Act gives those conditions that put in life the right to use experimental drugs, as long as the drug has finished at least one clinical trial and remains under investigation. This means that access to a synthetic version of psilocybin, if not the natural product, should have been available at least two years ago.

Laboratory-produced psilocybin, the psychoactive chemical commonly found in psilocybe fungi, has completed Phase 1 and Phase 2 trials, remains under investigation, and has been designated as a “revolutionary therapy” by the Federal Administration. of Drug. But the DEA has prevented terminally ill people from receiving the drug for nearly two years, incorrectly citing the Controlled Substances Act and the status of psilocybin as a Schedule I drug.

The list of protesters is published

Numerous people attended the rally and engaged in nonviolent civil disobedience to protest the unjust stonewalling by the DEA. Key participants will include:

  • Erinn Baldeschwiler – A terminally ill cancer patient from Seattle, Washington who has been waiting for more than a year to receive psilocybin therapy from her palliative care doctor.
  • Kim Larsen – Palliative Care Nurse at the Institute for Advanced Integrative Medical Sciences
  • Kathryn Tucker – Senior Defender of Patients’ Rights, Erinn’s lawyer leading legal challenge to force DEA to allow access
  • Dr. Mikhail Kogan – Medical Director of the George Washington University Center for Integrative Medicine, which provides medical care to terminally ill patients who may benefit from psilocybin therapy.
  • David Bronner – Cosmic Engagement Officer of Dr. Bronner’s Soaps, the country’s organic and proud soap company.
  • Eric Swenson – Caregiver, whose partner died of a terminal illness in 2000, and is an advocate for psilocybin therapy.
  • Melissa Lavasani – Executive Director of the Coalition of Psychedelic Medicine, Proponent of Initiative 81, President of Decriminalize Nature DC
  • Adam Eidinger – Co-founder of Decriminalize Nature DC is a bladder cancer patient

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
3,429FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles